A young man treated with Elevidys died of acute liver failure. The case may give doctors pause before prescribing the ...

Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers ...

The round will fund a “one-and-done” treatment for a rare kidney condition that its CEO says can address concerns patients ...

At least three new startups have already been launched out of the fund: U.K.-based Forth Therapeutics, French biotech ...

The pharma will acquire Araris Biotech to gain access to three preclinical ADCs and a linking technology Araris claims is superior to existing platforms.

The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...

Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...

With the right strategy, reaching LPI ahead of schedule isn’t a myth. Learn how some biotech and pharma teams are achieving ...

The agency formulated its advice to manufacturers after coordinating with the CDC and Defense Department. An advisory meeting ...

The deal ends 2Seventy’s short run as an independent company, during which it restructured, sold off research and lost nearly ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...